adenosine has been researched along with Psoriasis in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 6 (35.29) | 2.80 |
| Authors | Studies |
|---|---|
| Amento, E; Kang, GJ; Kaur, M; Mechanic, J; Ravikumar, P; Welihinda, A; Yadav, S | 1 |
| Cai, Y; Dai, Y; Li, J; Long, X; Peng, X; Shang, M; Wang, Q; Xia, C; Xian, J | 1 |
| Fu, J; Gao, Y; Han, X; Huang, S; Li, W; Liang, Q; Xia, L; Xiao, W; Yang, L; Yu, H; Zhang, C; Zhou, Y; Zhu, R | 1 |
| Ciruela, F; Jacobson, KA | 1 |
| Huang, J; Jin, H; Wang, Y | 1 |
| Cabré, G; Ciruela, F; Filgaira, I; Hernando, J; Jacobson, KA; López-Cano, M; Nolen, EG; Soler, C; Tosh, DK | 1 |
| Avni, D; Barzilai, A; Eisenberg, E; Feiglin, A; Greenberger, S; Kopel, E; Leichner, GS; Levanon, EY; Shallev, L; Sidi, Y | 1 |
| Almasri, IM; Kaur, A; Naik, RR; Shakya, AK | 1 |
| Warren, RB; Yiu, ZZ | 1 |
| Benea, V; Bristol, DR; Cohen, S; Cosgarea, MR; Cristodor, P; David, M; Demerdjieva, ZV; Farbstein, M; Fishman, P; Gheorghe, N; Giurcaneanu, C; Gospodinov, DK; Harpaz, Z; Hitova, MC; Horia, B; Hristakieva, E; Kadurina, MI; Mateev, GS; Michael, Z; Morariu, HS; Nica, C; Patel, RV; Purcaru, AI; Ramon, M; Rotaru, M; Rusinova, MV; Silverman, MH; Simionescu, O; Solovastru, LG; Tsingov, II; Yankova, RK | 1 |
| Borea, PA; Gessi, S; Merighi, S; Varani, K | 1 |
| Akerman, L; David, M; Fishman, P; Gospodinov, D; Kadurina, M; Kouzeva, V; Pavlotsky, F; Ramon, M; Silverman, MH; Yankova, R; Ziv, M | 1 |
| Famoso, G; Forchetti, G; Giovagnoni, A; Iliceto, S; Maddalozzo, A; Montisci, R; Osto, E; Peserico, A; Piaserico, S; Tona, F | 1 |
| Hadame, K; Mori, N; Sakakibara, S; Yoshikawa, K | 1 |
| Duell, EA | 1 |
| Baggott, JE; Linden, J; Morgan, SL; Sams, WM | 1 |
| Elder, JT; Fisher, GJ; Lee, CS; Pike, MC; Voorhees, JJ | 1 |
3 review(s) available for adenosine and Psoriasis
| Article | Year |
|---|---|
Role and Function of Adenosine and its Receptors in Inflammation, Neuroinflammation, IBS, Autoimmune Inflammatory Disorders, Rheumatoid Arthritis and Psoriasis.
Topics: Adenosine; Arthritis, Rheumatoid; Autoimmune Diseases; Humans; Inflammation; Irritable Bowel Syndrome; Psoriasis; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1 | 2019 |
Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.
Topics: Adamantane; Adenosine; Adenosine A3 Receptor Antagonists; Administration, Oral; Arthritis, Psoriatic; Azetidines; Biological Factors; Biological Therapy; Clinical Trials as Topic; Humans; Isonicotinic Acids; Janus Kinases; Niacinamide; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Lysosphingolipid; rho-Associated Kinases; Sulfonamides; Thalidomide; Thiazoles | 2016 |
Deregulation of Adenosine Receptors in Psoriatic Epidermis: An Option for Therapeutic Treatment.
Topics: Adenosine; Cell Proliferation; Cells, Cultured; Down-Regulation; Epidermis; Gene Expression Regulation; Humans; Keratinocytes; Molecular Targeted Therapy; Psoriasis; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1 | 2017 |
2 trial(s) available for adenosine and Psoriasis
| Article | Year |
|---|---|
Treatment of Plaque-Type Psoriasis With Oral CF101: Data from a Phase II/III Multicenter, Randomized, Controlled Trial.
Topics: Adenosine; Administration, Oral; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Psoriasis; Statistics as Topic; Treatment Outcome; Young Adult | 2016 |
Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial.
Topics: Adenosine; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Psoriasis; Treatment Outcome | 2012 |
12 other study(ies) available for adenosine and Psoriasis
| Article | Year |
|---|---|
Positive Allosteric Modulation of A
Topics: Adenosine; Animals; Cytokines; Dermatitis; Disease Models, Animal; Imiquimod; Immunity; Interleukin-17; Interleukin-23; Mice; Mice, Inbred BALB C; Psoriasis; Skin | 2022 |
N
Topics: Adenosine; Adolescent; Adult; Case-Control Studies; Child; Female; Humans; Keratinocytes; Male; Methyltransferases; MicroRNAs; Middle Aged; Proto-Oncogene Proteins c-akt; Psoriasis; RNA, Long Noncoding; Up-Regulation; Young Adult | 2022 |
Hsa_circ_0004287 inhibits macrophage-mediated inflammation in an N
Topics: Adenosine; Animals; Dermatitis, Atopic; Humans; Inflammation; Leukocytes, Mononuclear; Macrophages; Mice; MicroRNAs; Psoriasis; RNA, Circular; RNA, Long Noncoding | 2022 |
Optical Control of Adenosine A
Topics: Adenosine; Humans; Phototherapy; Psoriasis; Signal Transduction | 2022 |
Reduction of Methyltransferase-like 3-Mediated RNA N6-Methyladenosine Exacerbates the Development of Psoriasis Vulgaris in Imiquimod-Induced Psoriasis-like Mouse Model.
Topics: Adenosine; Animals; Disease Models, Animal; Humans; Imiquimod; Inflammation; Methyltransferases; Mice; Psoriasis; RNA; RNA, Messenger | 2022 |
Optical control of adenosine A
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Disease Models, Animal; Interleukin-23; Ligands; Photochemotherapy; Psoriasis; Receptor, Adenosine A3; Signal Transduction; Skin | 2021 |
Decreased A-to-I RNA editing as a source of keratinocytes' dsRNA in psoriasis.
Topics: Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Cells, Cultured; Connective Tissue Growth Factor; Copper-Transporting ATPases; Escherichia coli Proteins; Female; Filamins; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Humans; Inosine; Keratinocytes; Male; Middle Aged; Psoriasis; RNA Editing; RNA, Double-Stranded; Young Adult | 2018 |
Impaired coronary flow reserve in young patients affected by severe psoriasis.
Topics: Adenosine; Adult; Anti-Inflammatory Agents; Blood Flow Velocity; Case-Control Studies; Chi-Square Distribution; Coronary Angiography; Coronary Disease; Coronary Vessels; Echocardiography, Doppler, Color; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Italy; Linear Models; Logistic Models; Male; Microcirculation; Multivariate Analysis; Observer Variation; Odds Ratio; Predictive Value of Tests; Psoriasis; Reproducibility of Results; Risk Assessment; Risk Factors; Severity of Illness Index; Vasodilator Agents | 2012 |
Differences in response of psoriatic epidermis in cyclic AMP accumulation against certain adenyl cyclase agonists.
Topics: Adenosine; Adenylyl Cyclases; Animals; Cyclic AMP; Drug Synergism; Epidermis; Epinephrine; Histamine; Humans; Psoriasis; Swine | 1980 |
Adenosine-induced alterations in the adenosine 3':5'-monophosphate levels in mammalian epidermis.
Topics: Adenosine; Animals; Animals, Newborn; Cyclic AMP; Dipyridamole; Humans; In Vitro Techniques; Male; Mice; Psoriasis; Skin; Theophylline | 1980 |
Urinary adenosine and aminoimidazolecarboxamide excretion in methotrexate-treated patients with psoriasis.
Topics: Adenosine; Adult; Aged; Aminoimidazole Carboxamide; Female; Folic Acid Antagonists; Humans; Hydroxymethyl and Formyl Transferases; Male; Methotrexate; Middle Aged; Phosphoribosylaminoimidazolecarboxamide Formyltransferase; Psoriasis; Ribonucleotides | 1999 |
Increased phosphatidylinositol kinase activity in psoriatic epidermis.
Topics: 1-Phosphatidylinositol 4-Kinase; Adenosine; Cations, Divalent; Chromatography, Affinity; Cyclosporins; Detergents; Epidermis; Humans; Kinetics; Molecular Weight; Phosphotransferases; Polyamines; Psoriasis; Reference Values; Solubility | 1989 |